Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Some experts suggest changing treatment guidelines to include Cabenuva for those without viral suppression when other options aren’t working
All participants with detectable HIV on oral meds achieved viral suppression after switching to long-acting injectables.
Today’s HIV treatment is more effective and durable.
People who used once-weekly oral lenacapavir maintained viral suppression when injections were interrupted.
Long-acting therapies are the future of HIV treatment and prevention.
Long-acting injectables made Josh Kruger rethink HIV treatment, activism and the size of his butt.
Once-daily Biktarvy, long-acting injectable Cabenuva and two-drug combos containing dolutegravir can keep HIV in check for years.
Disruption of fat metabolism and altered gut microbiome may help explain weight changes associated with antiretroviral therapy.
People starting on integrase inhibitors were no more likely to have heart attacks, strokes or cardiovascular procedures.
Some people found thigh injections less painful than butt shots, and this could potentially enable self-administration at home.
People at a safety-net HIV clinic who struggle with adherence had viral suppression rates comparable to those seen in clinical trials.
The clinic has pioneered innovations that have been adopted nationwide and around the world.
The new injectable antiretroviral keeps HIV under control, but it still needs an equally long-acting partner.
HIV treatment has greatly improved over the past 36 years.
HIV treatment has come a long way, but there’s still room for innovation.
This year’s most widely viewed science news focused on HIV cure research, monkeypox and PEP for sexually transmitted infections.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.